Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1992 2
1998 1
2001 1
2002 3
2003 2
2004 2
2005 2
2006 5
2007 9
2008 6
2009 12
2010 12
2011 14
2012 14
2013 16
2014 24
2015 15
2016 21
2017 20
2018 27
2019 27
2020 27
2021 52
2022 39
2023 24
2024 23
2025 28
2026 21

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

382 results

Results by year

Filters applied: . Clear all
Page 1
Whole-Body Functional MRI and PET/MRI in Multiple Myeloma.
Mulé S, Reizine E, Blanc-Durand P, Baranes L, Zerbib P, Burns R, Nouri R, Itti E, Luciani A. Mulé S, et al. Cancers (Basel). 2020 Oct 27;12(11):3155. doi: 10.3390/cancers12113155. Cancers (Basel). 2020. PMID: 33121132 Free PMC article. Review.
Bone disease is one of the major features of multiple myeloma (MM), and imaging has a pivotal role in both diagnosis and follow-up. Whole-body magnetic resonance imaging (MRI) is recognized as the gold standard for th …
Bone disease is one of the major features of multiple myeloma (MM), and imaging has a pivotal role in both diagnosis an …
Guidelines for Acquisition, Interpretation, and Reporting of Whole-Body MRI in Myeloma: Myeloma Response Assessment and Diagnosis System (MY-RADS).
Messiou C, Hillengass J, Delorme S, Lecouvet FE, Moulopoulos LA, Collins DJ, Blackledge MD, Abildgaard N, Østergaard B, Schlemmer HP, Landgren O, Asmussen JT, Kaiser MF, Padhani A. Messiou C, et al. Radiology. 2019 Apr;291(1):5-13. doi: 10.1148/radiol.2019181949. Epub 2019 Feb 26. Radiology. 2019. PMID: 30806604
Acknowledging the increasingly important role of whole-body MRI for directing patient care in myeloma, a multidisciplinary, international, and expert panel of radiologists, medical physicists, and hematologists with specific expertise in whole- …
Acknowledging the increasingly important role of whole-body MRI for directing patient care in myeloma, a multidi …
Whole-Body Imaging of Multiple Myeloma: Diagnostic Criteria.
Ormond Filho AG, Carneiro BC, Pastore D, Silva IP, Yamashita SR, Consolo FD, Hungria VTM, Sandes AF, Rizzatti EG, Nico MAC. Ormond Filho AG, et al. Radiographics. 2019 Jul-Aug;39(4):1077-1097. doi: 10.1148/rg.2019180096. Radiographics. 2019. PMID: 31283452 Review.
Multiple myeloma (MM) is a clonal plasma cell proliferative disorder characterized by primary infiltration of bone marrow and excessive production of abnormal immunoglobulin. ...Whole-body low-dose CT is a reasonable and cost-effective initial imagi …
Multiple myeloma (MM) is a clonal plasma cell proliferative disorder characterized by primary infiltration of bone marrow and …
Whole-Body Imaging in Multiple Myeloma.
Messiou C, Kaiser M. Messiou C, et al. Magn Reson Imaging Clin N Am. 2018 Nov;26(4):509-525. doi: 10.1016/j.mric.2018.06.006. Magn Reson Imaging Clin N Am. 2018. PMID: 30316464 Free article. Review.
This article outlines current international guidance for the role of imaging in myeloma and summarizes evidence regarding the role of whole-body MR imaging in diagnosis and response assessment. Whole-body MR imaging protocol …
This article outlines current international guidance for the role of imaging in myeloma and summarizes evidence regarding the …
International myeloma working group consensus recommendations on imaging in monoclonal plasma cell disorders.
Hillengass J, Usmani S, Rajkumar SV, Durie BGM, Mateos MV, Lonial S, Joao C, Anderson KC, García-Sanz R, Riva E, Du J, van de Donk N, Berdeja JG, Terpos E, Zamagni E, Kyle RA, San Miguel J, Goldschmidt H, Giralt S, Kumar S, Raje N, Ludwig H, Ocio E, Schots R, Einsele H, Schjesvold F, Chen WM, Abildgaard N, Lipe BC, Dytfeld D, Wirk BM, Drake M, Cavo M, Lahuerta JJ, Lentzsch S. Hillengass J, et al. Lancet Oncol. 2019 Jun;20(6):e302-e312. doi: 10.1016/S1470-2045(19)30309-2. Lancet Oncol. 2019. PMID: 31162104 Review.
Given the multiple options available for the detection of bone and bone marrow lesions, ranging from conventional skeletal survey to whole-body CT, PET/CT, and MRI, the International Myeloma Working Group decided to establish guidelines on optim …
Given the multiple options available for the detection of bone and bone marrow lesions, ranging from conventional skeletal survey to …
Review of whole-body magnetic resonance imaging in multiple myeloma.
Perillo T, Giorgio C, Fico A, Perrotta M, Serino A, Cuocolo R, Manto A. Perillo T, et al. Jpn J Radiol. 2024 Dec;42(12):1381-1391. doi: 10.1007/s11604-024-01635-y. Epub 2024 Aug 1. Jpn J Radiol. 2024. PMID: 39088009 Review.
Multiple Myeloma (MM) is a hematological malignancy affecting bone marrow, most frequently in elderly men. ...Aim of this review is to provide an overview of the role and main imaging findings of whole-body MRI in MM....
Multiple Myeloma (MM) is a hematological malignancy affecting bone marrow, most frequently in elderly men. ...Aim of this revi …
Whole body MRI by MY-RADS for imaging response assessment in multiple myeloma.
Messiou C, Porta N, Koh DM, Riddell A, Downey K, Croft J, Conneely L, Hopkinson G, Dragan A, Brown T, Stern S, Cheung B, Kyriakou C, Kaczmarek P, Boyd K, Pawlyn C, Winfield J, Kaiser MF. Messiou C, et al. Blood Cancer J. 2025 Jul 17;15(1):122. doi: 10.1038/s41408-025-01327-4. Blood Cancer J. 2025. PMID: 40675973 Free PMC article.
Minimal residual disease (MRD) testing has underpinned the evaluation and expansion of therapeutic options for patients with multiple myeloma (MM). Imaging is essential for evaluating residual disease status, overcoming sampling errors inherent with other MRD …
Minimal residual disease (MRD) testing has underpinned the evaluation and expansion of therapeutic options for patients with multiple …
Whole-body MRI, dynamic contrast-enhanced MRI, and diffusion-weighted imaging for the staging of multiple myeloma.
Dutoit JC, Verstraete KL. Dutoit JC, et al. Skeletal Radiol. 2017 Jun;46(6):733-750. doi: 10.1007/s00256-017-2609-6. Epub 2017 Mar 13. Skeletal Radiol. 2017. PMID: 28289855 Review.
Magnetic resonance imaging (MRI) is the most sensitive imaging technique for the detection of bone marrow infiltration, and has therefore recently been included in the new diagnostic myeloma criteria, as proposed by the International M …
Magnetic resonance imaging (MRI) is the most sensitive imaging technique for the detection of bone marrow …
Comparative Performance of Whole-Body MRI and FDG PET/CT in Evaluation of Multiple Myeloma Treatment Response: Systematic Review and Meta-Analysis.
Rama S, Suh CH, Kim KW, Durieux JC, Ramaiya NH, Tirumani SH. Rama S, et al. AJR Am J Roentgenol. 2022 Apr;218(4):602-613. doi: 10.2214/AJR.21.26381. Epub 2021 Oct 27. AJR Am J Roentgenol. 2022. PMID: 34704461
Traditional approaches for evaluating multiple myeloma (MM) treatment response have low sensitivity for residual disease. Recent studies highlight the utility of whole-body MRI or FDG PET/CT in evaluating treatment response, with increasing emph …
Traditional approaches for evaluating multiple myeloma (MM) treatment response have low sensitivity for residual disease. Rece …
382 results